[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Stem Cell Therapy Products Market Report 2017

November 2017 | 104 pages | ID: U7A8F0D1A19WEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Stem Cell Therapy Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Stem Cell Therapy Products in these regions, from 2012 to 2022 (forecast).
United States Stem Cell Therapy Products market competition by top manufacturers/players, with Stem Cell Therapy Products sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Mesoblast
  • TiGenix
  • Osiris
  • Medi-post
  • New York Blood Center
  • Anterogen
  • Pharmicell
  • ClinImmune
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Autologous
  • Bone marrow stem cells
  • Umbilical cord blood stem cells
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Stem Cell Therapy Products for each application, including
  • Knee Cartilage Defects
  • Type I Diabetes
  • Children GvHD
  • Bone Repair
  • Acute Myocardial Infarction
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Stem Cell Therapy Products Market Report 2017

1 STEM CELL THERAPY PRODUCTS OVERVIEW

1.1 Product Overview and Scope of Stem Cell Therapy Products
1.2 Classification of Stem Cell Therapy Products by Product Category
  1.2.1 United States Stem Cell Therapy Products Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Stem Cell Therapy Products Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Autologous
  1.2.4 Bone marrow stem cells
  1.2.5 Umbilical cord blood stem cells
1.3 United States Stem Cell Therapy Products Market by Application/End Users
  1.3.1 United States Stem Cell Therapy Products Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Knee Cartilage Defects
  1.3.3 Type I Diabetes
  1.3.4 Children GvHD
  1.3.5 Bone Repair
  1.3.6 Acute Myocardial Infarction
1.4 United States Stem Cell Therapy Products Market by Region
  1.4.1 United States Stem Cell Therapy Products Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Stem Cell Therapy Products Status and Prospect (2012-2022)
  1.4.3 Southwest Stem Cell Therapy Products Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Stem Cell Therapy Products Status and Prospect (2012-2022)
  1.4.5 New England Stem Cell Therapy Products Status and Prospect (2012-2022)
  1.4.6 The South Stem Cell Therapy Products Status and Prospect (2012-2022)
  1.4.7 The Midwest Stem Cell Therapy Products Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Stem Cell Therapy Products (2012-2022)
  1.5.1 United States Stem Cell Therapy Products Sales and Growth Rate (2012-2022)
  1.5.2 United States Stem Cell Therapy Products Revenue and Growth Rate (2012-2022)

2 UNITED STATES STEM CELL THERAPY PRODUCTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Stem Cell Therapy Products Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Stem Cell Therapy Products Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Stem Cell Therapy Products Average Price by Players/Suppliers (2012-2017)
2.4 United States Stem Cell Therapy Products Market Competitive Situation and Trends
  2.4.1 United States Stem Cell Therapy Products Market Concentration Rate
  2.4.2 United States Stem Cell Therapy Products Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Stem Cell Therapy Products Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES STEM CELL THERAPY PRODUCTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Stem Cell Therapy Products Sales and Market Share by Region (2012-2017)
3.2 United States Stem Cell Therapy Products Revenue and Market Share by Region (2012-2017)
3.3 United States Stem Cell Therapy Products Price by Region (2012-2017)

4 UNITED STATES STEM CELL THERAPY PRODUCTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Stem Cell Therapy Products Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Stem Cell Therapy Products Revenue and Market Share by Type (2012-2017)
4.3 United States Stem Cell Therapy Products Price by Type (2012-2017)
4.4 United States Stem Cell Therapy Products Sales Growth Rate by Type (2012-2017)

5 UNITED STATES STEM CELL THERAPY PRODUCTS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Stem Cell Therapy Products Sales and Market Share by Application (2012-2017)
5.2 United States Stem Cell Therapy Products Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES STEM CELL THERAPY PRODUCTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Mesoblast
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Stem Cell Therapy Products Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Mesoblast Stem Cell Therapy Products Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 TiGenix
  6.2.2 Stem Cell Therapy Products Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 TiGenix Stem Cell Therapy Products Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Osiris
  6.3.2 Stem Cell Therapy Products Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Osiris Stem Cell Therapy Products Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Medi-post
  6.4.2 Stem Cell Therapy Products Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Medi-post Stem Cell Therapy Products Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 New York Blood Center
  6.5.2 Stem Cell Therapy Products Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 New York Blood Center Stem Cell Therapy Products Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Anterogen
  6.6.2 Stem Cell Therapy Products Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Anterogen Stem Cell Therapy Products Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pharmicell
  6.7.2 Stem Cell Therapy Products Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pharmicell Stem Cell Therapy Products Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 ClinImmune
  6.8.2 Stem Cell Therapy Products Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 ClinImmune Stem Cell Therapy Products Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 STEM CELL THERAPY PRODUCTS MANUFACTURING COST ANALYSIS

7.1 Stem Cell Therapy Products Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Stem Cell Therapy Products

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Stem Cell Therapy Products Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Stem Cell Therapy Products Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES STEM CELL THERAPY PRODUCTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Stem Cell Therapy Products Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Stem Cell Therapy Products Sales Volume Forecast by Type (2017-2022)
11.3 United States Stem Cell Therapy Products Sales Volume Forecast by Application (2017-2022)
11.4 United States Stem Cell Therapy Products Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Stem Cell Therapy Products
Figure United States Stem Cell Therapy Products Market Size (Unit) by Type (2012-2022)
Figure United States Stem Cell Therapy Products Sales Volume Market Share by Type (Product Category) in 2016
Figure Autologous Product Picture
Figure Bone marrow stem cells Product Picture
Figure Umbilical cord blood stem cells Product Picture
Figure United States Stem Cell Therapy Products Market Size (Unit) by Application (2012-2022)
Figure United States Sales Market Share of Stem Cell Therapy Products by Application in 2016
Figure Knee Cartilage Defects Examples
Table Key Downstream Customer in Knee Cartilage Defects
Figure Type I Diabetes Examples
Table Key Downstream Customer in Type I Diabetes
Figure Children GvHD Examples
Table Key Downstream Customer in Children GvHD
Figure Bone Repair Examples
Table Key Downstream Customer in Bone Repair
Figure Acute Myocardial Infarction Examples
Table Key Downstream Customer in Acute Myocardial Infarction
Figure United States Stem Cell Therapy Products Market Size (Million USD) by Region (2012-2022)
Figure The West Stem Cell Therapy Products Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Stem Cell Therapy Products Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Stem Cell Therapy Products Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Stem Cell Therapy Products Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Stem Cell Therapy Products Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Stem Cell Therapy Products Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Stem Cell Therapy Products Sales (Unit) and Growth Rate (2012-2022)
Figure United States Stem Cell Therapy Products Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Stem Cell Therapy Products Market Major Players Product Sales Volume (Unit) (2012-2017)
Table United States Stem Cell Therapy Products Sales (Unit) of Key Players/Suppliers (2012-2017)
Table United States Stem Cell Therapy Products Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Stem Cell Therapy Products Sales Share by Players/Suppliers
Figure 2017 United States Stem Cell Therapy Products Sales Share by Players/Suppliers
Figure United States Stem Cell Therapy Products Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Stem Cell Therapy Products Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Stem Cell Therapy Products Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Stem Cell Therapy Products Revenue Share by Players/Suppliers
Figure 2017 United States Stem Cell Therapy Products Revenue Share by Players/Suppliers
Table United States Market Stem Cell Therapy Products Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Stem Cell Therapy Products Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Stem Cell Therapy Products Market Share of Top 3 Players/Suppliers
Figure United States Stem Cell Therapy Products Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Stem Cell Therapy Products Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Stem Cell Therapy Products Product Category
Table United States Stem Cell Therapy Products Sales (Unit) by Region (2012-2017)
Table United States Stem Cell Therapy Products Sales Share by Region (2012-2017)
Figure United States Stem Cell Therapy Products Sales Share by Region (2012-2017)
Figure United States Stem Cell Therapy Products Sales Market Share by Region in 2016
Table United States Stem Cell Therapy Products Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Stem Cell Therapy Products Revenue Share by Region (2012-2017)
Figure United States Stem Cell Therapy Products Revenue Market Share by Region (2012-2017)
Figure United States Stem Cell Therapy Products Revenue Market Share by Region in 2016
Table United States Stem Cell Therapy Products Price (USD/Unit) by Region (2012-2017)
Table United States Stem Cell Therapy Products Sales (Unit) by Type (2012-2017)
Table United States Stem Cell Therapy Products Sales Share by Type (2012-2017)
Figure United States Stem Cell Therapy Products Sales Share by Type (2012-2017)
Figure United States Stem Cell Therapy Products Sales Market Share by Type in 2016
Table United States Stem Cell Therapy Products Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Stem Cell Therapy Products Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Stem Cell Therapy Products by Type (2012-2017)
Figure Revenue Market Share of Stem Cell Therapy Products by Type in 2016
Table United States Stem Cell Therapy Products Price (USD/Unit) by Types (2012-2017)
Figure United States Stem Cell Therapy Products Sales Growth Rate by Type (2012-2017)
Table United States Stem Cell Therapy Products Sales (Unit) by Application (2012-2017)
Table United States Stem Cell Therapy Products Sales Market Share by Application (2012-2017)
Figure United States Stem Cell Therapy Products Sales Market Share by Application (2012-2017)
Figure United States Stem Cell Therapy Products Sales Market Share by Application in 2016
Table United States Stem Cell Therapy Products Sales Growth Rate by Application (2012-2017)
Figure United States Stem Cell Therapy Products Sales Growth Rate by Application (2012-2017)
Table Mesoblast Basic Information List
Table Mesoblast Stem Cell Therapy Products Sales (Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mesoblast Stem Cell Therapy Products Sales Growth Rate (2012-2017)
Figure Mesoblast Stem Cell Therapy Products Sales Market Share in United States (2012-2017)
Figure Mesoblast Stem Cell Therapy Products Revenue Market Share in United States (2012-2017)
Table TiGenix Basic Information List
Table TiGenix Stem Cell Therapy Products Sales (Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TiGenix Stem Cell Therapy Products Sales Growth Rate (2012-2017)
Figure TiGenix Stem Cell Therapy Products Sales Market Share in United States (2012-2017)
Figure TiGenix Stem Cell Therapy Products Revenue Market Share in United States (2012-2017)
Table Osiris Basic Information List
Table Osiris Stem Cell Therapy Products Sales (Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Osiris Stem Cell Therapy Products Sales Growth Rate (2012-2017)
Figure Osiris Stem Cell Therapy Products Sales Market Share in United States (2012-2017)
Figure Osiris Stem Cell Therapy Products Revenue Market Share in United States (2012-2017)
Table Medi-post Basic Information List
Table Medi-post Stem Cell Therapy Products Sales (Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medi-post Stem Cell Therapy Products Sales Growth Rate (2012-2017)
Figure Medi-post Stem Cell Therapy Products Sales Market Share in United States (2012-2017)
Figure Medi-post Stem Cell Therapy Products Revenue Market Share in United States (2012-2017)
Table New York Blood Center Basic Information List
Table New York Blood Center Stem Cell Therapy Products Sales (Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure New York Blood Center Stem Cell Therapy Products Sales Growth Rate (2012-2017)
Figure New York Blood Center Stem Cell Therapy Products Sales Market Share in United States (2012-2017)
Figure New York Blood Center Stem Cell Therapy Products Revenue Market Share in United States (2012-2017)
Table Anterogen Basic Information List
Table Anterogen Stem Cell Therapy Products Sales (Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Anterogen Stem Cell Therapy Products Sales Growth Rate (2012-2017)
Figure Anterogen Stem Cell Therapy Products Sales Market Share in United States (2012-2017)
Figure Anterogen Stem Cell Therapy Products Revenue Market Share in United States (2012-2017)
Table Pharmicell Basic Information List
Table Pharmicell Stem Cell Therapy Products Sales (Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pharmicell Stem Cell Therapy Products Sales Growth Rate (2012-2017)
Figure Pharmicell Stem Cell Therapy Products Sales Market Share in United States (2012-2017)
Figure Pharmicell Stem Cell Therapy Products Revenue Market Share in United States (2012-2017)
Table ClinImmune Basic Information List
Table ClinImmune Stem Cell Therapy Products Sales (Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ClinImmune Stem Cell Therapy Products Sales Growth Rate (2012-2017)
Figure ClinImmune Stem Cell Therapy Products Sales Market Share in United States (2012-2017)
Figure ClinImmune Stem Cell Therapy Products Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Stem Cell Therapy Products
Figure Manufacturing Process Analysis of Stem Cell Therapy Products
Figure Stem Cell Therapy Products Industrial Chain Analysis
Table Raw Materials Sources of Stem Cell Therapy Products Major Players/Suppliers in 2016
Table Major Buyers of Stem Cell Therapy Products
Table Distributors/Traders List
Figure United States Stem Cell Therapy Products Sales Volume (Unit) and Growth Rate Forecast (2017-2022)
Figure United States Stem Cell Therapy Products Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Stem Cell Therapy Products Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Stem Cell Therapy Products Sales Volume (Unit) Forecast by Type (2017-2022)
Figure United States Stem Cell Therapy Products Sales Volume (Unit) Forecast by Type (2017-2022)
Figure United States Stem Cell Therapy Products Sales Volume (Unit) Forecast by Type in 2022
Table United States Stem Cell Therapy Products Sales Volume (Unit) Forecast by Application (2017-2022)
Figure United States Stem Cell Therapy Products Sales Volume (Unit) Forecast by Application (2017-2022)
Figure United States Stem Cell Therapy Products Sales Volume (Unit) Forecast by Application in 2022
Table United States Stem Cell Therapy Products Sales Volume (Unit) Forecast by Region (2017-2022)
Table United States Stem Cell Therapy Products Sales Volume Share Forecast by Region (2017-2022)
Figure United States Stem Cell Therapy Products Sales Volume Share Forecast by Region (2017-2022)
Figure United States Stem Cell Therapy Products Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories